CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-25 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 347,155 | ||
| 2023-05-24 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-05-24 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −28,144 | $131.13 | $3.7M | 5,423,802 |
| 2023-05-24 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −9,820 | $131.98 | $1.3M | 5,413,982 |
| 2023-05-24 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −2,036 | $132.93 | $271K | 5,411,946 |
| 2023-05-24 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 387,155 | ||
| 2023-05-18 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-05-18 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −28,476 | $123.53 | $3.5M | 5,423,470 |
| 2023-05-18 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −10,653 | $124.31 | $1.3M | 5,412,817 |
| 2023-05-18 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −871 | $125.24 | $109K | 5,411,946 |
| 2023-05-18 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 427,155 | ||
| 2023-05-17 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-05-17 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −2,333 | $123.22 | $287K | 5,449,613 |
| 2023-05-17 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −9,350 | $124.24 | $1.2M | 5,440,263 |
| 2023-05-17 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −11,547 | $125.34 | $1.4M | 5,428,716 |
| 2023-05-17 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −16,248 | $126.17 | $2.1M | 5,412,468 |
| 2023-05-17 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −522 | $126.86 | $66K | 5,411,946 |
| 2023-05-17 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 467,155 | ||
| 2023-05-11 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-05-11 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −35,330 | $127.17 | $4.5M | 5,416,616 |
Page 46 of 66 · 1,314 trades